IP Verse

Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation

Patent No. EP3252160 (titled "Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation") was filed by Massachusetts Institute OF Technology on Dec 12, 2013. The application was issued on Oct 28, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JG OPPOSITIONSJul 28, 2021WILDING
SCHLICHJul 28, 2021SCHLICH
PATENT BOUTIQUEFeb 23, 2021PATENT BOUTIQUE
GRUNDNov 3, 2020GRUND
CRISPR THERAPEUTICSOct 29, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3252160

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP17162030A
Filing Date
Dec 12, 2013
Status
Granted And Under Opposition
Sep 25, 2020
Publication Date
Oct 28, 2020
External Links
Slate, Register , Google Patents